Effect of miR-26b on gestational diabetes mellitus in rats via PI3K/Akt signaling pathway

H-X Li1, X-H Li, J Jiang

  • 1Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. evibciq@163.com.

Abstract

Insights

Micro ribonucleic acid (miR)-26b exacerbates gestational diabetes in rats by inhibiting the phosphatidylinositol 3-hydroxy kinase/protein kinase B (PI3K/Akt) pathway, worsening vascular damage and metabolic markers.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Vascular Biology

Background:

  • Gestational diabetes mellitus (GDM) poses risks to maternal and fetal health.
  • The role of microRNAs (miRNAs) in GDM pathogenesis is an area of active research.
  • The phosphatidylinositol 3-hydroxy kinase/protein kinase B (PI3K/Akt) pathway is crucial in metabolic regulation.

Purpose of the Study:

  • To investigate the effect of miR-26b on GDM in a rat model.
  • To elucidate the involvement of the PI3K/Akt signaling pathway in miR-26b's influence on GDM.

Main Methods:

  • Utilized a rat model of GDM, with groups including normal, GDM model, and GDM model treated with miR-26b.
  • Assessed fasting blood glucose (FBG) and C-reactive protein (CRP) levels.
  • Analyzed thoracic aortic intima and media morphology.
  • Quantified PI3K/Akt pathway activation using qRT-PCR and Western blotting.

Main Results:

  • GDM model rats showed significantly elevated FBG and CRP levels compared to normal rats.
  • miR-26b treatment in GDM rats further increased FBG and CRP and worsened vascular lesions.
  • Expression of phosphorylated PI3K (p-PI3K) and phosphorylated Akt (p-Akt) was significantly downregulated in GDM rats, with further reduction upon miR-26b administration.

Conclusions:

  • MiR-26b accelerates GDM progression in rats.
  • The mechanism involves the inhibition of the PI3K/Akt signaling pathway.
  • These findings highlight miR-26b as a potential therapeutic target in GDM.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K